Back to News
Market Impact: 0.18
State Street SPDR S&P Biotech ETF Experiences Big Inflow
Source: Nasdaq
Market Technicals & FlowsInvestor Sentiment & Positioning
State Street SPDR S&P Biotech ETF (XBI) saw an approximate $289.4M inflow, up 2.6% week-over-week, indicating modest positive momentum in biotech exposure. While this is a sentiment/flow signal rather than a fundamental catalyst, it could provide some near-term support to XBI and related biotech risk.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
More News
- State Street Sees Resilience Driving Portfolios
- Bloomberg This Weekend 9/20/2026
- Stock futures are little changed after Dow posts third straight losing week: Live updates
- As high fuel costs force people to choose between filling up or buying groceries, Trump says ‘it’s a very inexpensive price to pay’ for the Iran war
- Iran war live: Tehran warns US against new strikes; fighting rages in Yemen
- Citi CEO Says Companies Scrambling to Launch AI Cyber Defenses
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: Adding Live MBO Level 3 Data - Liquidity Heatmap, OFI Charts, and More
- Alternative Data Due Diligence for Institutional Investors